Jim Ziegler
Vermögen: 125 000 $ am 31.05.2026
Vermögen: 125 000 $ am 31.05.2026
Jim Ziegler formerly worked at Amgen, Inc., as Head-Sales & Marketing, Gilead Sciences, Inc., as VP-Cardiopulmonary & Inflammation, Pfizer Inc., as Head-Sales & Marketing, Biogen, Inc., as Head-Sales & Marketing, Nodality, Inc., as Vice President-Sales & Marketing, The United States Army (District of Columbia), as Principal, Iovance Biotherapeutics, Inc., as Executive Vice President-Commercial, and Geron Corp., as Chief Commercial Officer & Executive VP.
Mr. Ziegler received his Masters Business Admin degree from The University of Chicago and undergraduate degree from US Military Academy.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
GERON CORPORATION 0,02 % | 26.03.2026 | 100 000 ( 0,02 % ) | 125 000 $ | 31.05.2026 |
| Unternehmen | Position | Ende |
|---|---|---|
| GERON CORPORATION | Corporate Officer/Principal | - |
The United States Army (District of Columbia)
The United States Army (District of Columbia) SovereignGovernment Engages in army operations | Corporate Officer/Principal | - |
| IOVANCE BIOTHERAPEUTICS, INC. | Corporate Officer/Principal | - |
| GILEAD SCIENCES, INC. | Corporate Officer/Principal | - |
| BIOGEN INC. | Vertrieb & Marketing | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
| Private Unternehmen | 10 |
|---|---|
Amgen, Inc.
Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Gilead Sciences, Inc.
Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
Pfizer Inc.
Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Biogen, Inc.
Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Geron Corp.
Geron Corp. BiotechnologyHealth Technology Discovers and develops therapeutic products for cancer | Health Technology |
Nodality, Inc.
Nodality, Inc. BiotechnologyHealth Technology Develops bioinformatics tools to enhance drug development process | Health Technology |
The University of Chicago
The University of Chicago Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
US Military Academy
US Military Academy Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The United States Army (District of Columbia)
The United States Army (District of Columbia) SovereignGovernment Engages in army operations | Government |
Iovance Biotherapeutics, Inc.
Iovance Biotherapeutics, Inc. BiotechnologyHealth Technology Develops biotechnological products for the treatment of cancer | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen